Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Toxicol Ind Health ; 31(10): 911-9, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23572392

RESUMO

Direct-type catalytic Mannich reaction for the synthesis of ß-aminoketones from cyclohexanone, substituted aromatic amines and aromatic or hetero-aromatic aldehydes has been applied in water with bismuth triflate under ultrasound. Good yields of the expected ß-aminoketones were obtained from available substrates, at room temperature in 1-2 hours. This study was designed to evaluate the mutagenic and antimutagenic potential of synthesized ß-aminoketones compounds using Ames/Salmonella and Escherichia coli WP2 bacterial reverse mutation assay systems.


Assuntos
Cetonas/farmacologia , Mesilatos/química , Mutagênicos/farmacologia , Substâncias Protetoras/farmacologia , Bactérias/efeitos dos fármacos , Bactérias/genética , Cetonas/síntese química , Viabilidade Microbiana/efeitos dos fármacos , Mutação/efeitos dos fármacos , Substâncias Protetoras/síntese química , Sonicação
2.
Acta Chim Slov ; 61(3): 623-8, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25286219

RESUMO

An effective and environment-friendly protocol for the synthesis of indenonaphthopyrans has been developed by one-pot reaction of 2-naphthol, various aromatic aldehydes and 1,3-indandione, in the presence of copper(II) triflate as the catalyst while using reflux (Method A) and ultrasound (Method B). The Method B approach offers the advantages of a simple reaction method, short reaction time, excellent yield, and showcases the economic importance of the catalysts for such processes.

3.
Drug Chem Toxicol ; 37(4): 365-9, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24341665

RESUMO

The goal of the present research was to determine the protective potential of five newly synthesized indenopyridine derivatives against N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and 9-aminoacridine (9-AA) induced mutagenesis. MNNG sensitive Escherichia coli WP2uvrA and 9-AA sensitive Salmonella typhimurium TA1537 were chosen as the bacterial tester strains. All of the test compounds showed significant antimutagenic activity at various tested concentrations. The inhibition rates ranged from 25.6% (Compound 2 - 1 mM/plate) to 68.2% (Compound 1 - 2.5 mM/plate) for MNNG and from 25.7% (Compound 4 - 1 mM/plate) to 76.1% (Compound 3 - 2.5 mM/plate) for 9-AA genotoxicity. Moreover, the mutagenicity of the test compounds was investigated by using the same strains. None of the test compounds has mutagenic properties on the bacterial strains at the highest concentration of 2.5 mM. Thus, the findings of the present study give valuable clues to develop new strategies for chemical prevention from MNNG and 9-AA genotoxicity by using synthetic indenopyridine derivatives.


Assuntos
Antimutagênicos/farmacologia , Indenos/farmacologia , Mutagênicos/toxicidade , Piridinas/farmacologia , Aminacrina/toxicidade , Antimutagênicos/administração & dosagem , Antimutagênicos/química , Relação Dose-Resposta a Droga , Escherichia coli/genética , Indenos/administração & dosagem , Indenos/química , Metilnitronitrosoguanidina/toxicidade , Testes de Mutagenicidade , Piridinas/administração & dosagem , Piridinas/química , Salmonella typhimurium/genética
4.
Toxicol Ind Health ; 30(3): 275-83, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22903173

RESUMO

The current study aims to determine the genotoxic and antigenotoxic potential of four newly synthesized dihydropyridine derivatives using Escherichia coli WP2 and Ames/Salmonella bacterial reversion assay systems. The bacterial mutant tester strains, E. coli WP2uvrA with a point mutation and Salmonella typhimurium TA1537 with a frameshift mutation, were used to determine genotoxic potentials of the test compounds. To determine antigenotoxic potentials of the test compounds, the same strains were also used together with positive mutagens N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) for E. coli WP2uvrA and 9-aminoacridine (9-AA) for S. typhimurium TA1537. According to the results, neither of the test compounds showed significant genotoxic activity on both tester strains at the tested concentrations. However, except compound 4, all the test compounds showed significant antigenotoxic activity on MNNG- or/and 9-AA-induced mutations. The inhibition rates of mutagenesis ranged from 27.0% (compound 2: 2.5 mM/plate) to 65.0% (compound 2: 0.5 mM/plate) for MNNG and from 30.6% (compound 2: 2 mM/plate) to 58.5% (compound 1: 1 mM/plate) for 9-AA genotoxicity. According to these results, it is concluded that all the test compounds do not have a mutagenic potential on the bacterial strains at the tested concentrations, and some of them have antigenotoxic potentials against MNNG- and 9-AA-induced mutagenesis.


Assuntos
Di-Hidropiridinas/toxicidade , Testes de Mutagenicidade/métodos , Mutagênicos/toxicidade , Aminacrina/toxicidade , Escherichia coli/efeitos dos fármacos , Escherichia coli/genética , Metilnitronitrosoguanidina/toxicidade , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/genética
5.
J Biochem Mol Toxicol ; 26(7): 258-63, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22645030

RESUMO

The aim of this study was to determine the antigenotoxic potential of two newly synthesized ß-aminoketones against N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and 9-aminoacridine (9-AA)-induced mutagenesis. The mutant bacterial tester strains were MNNG-sensitive Escherichia coli WP2 uvrA and 9-AA-sensitive Salmonella typhimurium TA1537. Both test compounds showed significant antimutagenic activity at various tested concentrations. The inhibition rates ranged from 29.5% (compound 1: 2 mM/plate) to 47.5% (compound 2: 1.5 mM/plate) for MNNG and from 25.0% (compound 2: 1 mM/plate) to 52.1% (compound 2: 2.5 mM/plate) for 9-AA genotoxicity. Moreover, the mutagenicity of the test compounds was investigated by using the same strains. Neither test compound has mutagenic properties on the bacterial strains at the tested concentrations. Thus, the findings of the present study give valuable information about chemical prevention from MNNG and 9-AA genotoxicity by using synthetic ß-aminoketones.


Assuntos
Aminacrina/toxicidade , Antimutagênicos , Cicloexanonas/farmacologia , Metilnitronitrosoguanidina/toxicidade , Viabilidade Microbiana/efeitos dos fármacos , Mutagênese , Antimutagênicos/síntese química , Antimutagênicos/farmacologia , Cicloexanonas/síntese química , Cicloexanonas/química , Antagonismo de Drogas , Escherichia coli/genética , Mutagênese/efeitos dos fármacos , Mutação/efeitos dos fármacos , Salmonella typhimurium/genética
6.
Toxicol Ind Health ; 28(7): 605-13, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21967842

RESUMO

The current study aims to determine the antimutagenic potential of five newly synthesized cyclic compounds against the genotoxic agents sodium azide (NaN3) and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). The mutant bacterial tester strains were NaN3-sensitive Salmonella typhimurium TA1535 and MNNG-sensitive Escherichia coli WP2uvrA. According to the results, all the test compounds showed significant antimutagenic activity. The inhibition rates ranged from 26.05% (Compound 4-1 µg/plate) to 68.54% (Compound 5-0.01 µg/plate) for NaN3 and from 32.44% (Compound 3-1 µg/plate) to 60.77% (Compound 5-1 µg/plate) for MNNG genotoxicity. Moreover, the mutagenic potential of the test compounds was investigated using the same strains. The results showed that all the test compounds do not have mutagenic potential on the bacterial strains at the tested concentrations. Thus, the findings of the present study give valuable information about chemical prevention from NaN3 and MNNG genotoxicity.


Assuntos
Antimutagênicos/farmacologia , Compostos Heterocíclicos/farmacologia , Metilnitronitrosoguanidina/toxicidade , Mutagênicos/toxicidade , Azida Sódica/toxicidade , Análise de Variância , Escherichia coli/efeitos dos fármacos , Escherichia coli/genética , Testes de Mutagenicidade , Mutação/efeitos dos fármacos , Mutação/genética , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...